Chloroquine Potentiates Primaquine Activity against Active and Latent Hepatic Plasmodia


Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
16 12 2020
Historique:
received: 04 07 2020
accepted: 12 10 2020
pubmed: 21 10 2020
medline: 22 6 2021
entrez: 20 10 2020
Statut: epublish

Résumé

For a long while, 8-aminoquinoline compounds have been the only therapeutic agents against latent hepatic malaria parasites. These have poor activity against the blood-stage plasmodia causing acute malaria and must be used in conjunction with partner blood schizontocidal agents. We examined the impacts of one such agent, chloroquine, upon the activity of primaquine, an 8-aminoquinoline, against hepatic stages of

Identifiants

pubmed: 33077656
pii: AAC.01416-20
doi: 10.1128/AAC.01416-20
pmc: PMC7927800
pii:
doi:

Substances chimiques

Antimalarials 0
Chloroquine 886U3H6UFF
Primaquine MVR3634GX1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2020 Dembélé et al.

Références

Am J Trop Med Hyg. 2011 Dec;85(6):1010-4
pubmed: 22144436
Malar J. 2018 Aug 13;17(1):294
pubmed: 30103751
Cell Host Microbe. 2018 Mar 14;23(3):395-406.e4
pubmed: 29478773
Nat Med. 2014 Mar;20(3):307-12
pubmed: 24509527
Antimicrob Agents Chemother. 2016 Apr 22;60(5):2858-63
pubmed: 26926645
Malar J. 2011 Jul 29;10:212
pubmed: 21801400
Antimicrob Agents Chemother. 2014 Jun;58(6):3354-9
pubmed: 24687509
PLoS One. 2010 Dec 09;5(12):e14275
pubmed: 21151554
Antimicrob Agents Chemother. 2014;58(3):1586-95
pubmed: 24366744
J Lab Clin Med. 1955 Aug;46(2):301-6
pubmed: 13242948
PLoS One. 2011 Mar 31;6(3):e18162
pubmed: 21483865
Am J Trop Med Hyg. 1981 Jan;30(1):20-5
pubmed: 7212167
Sci Rep. 2014 Apr 23;4:4760
pubmed: 24755823
Nat Commun. 2018 May 9;9(1):1837
pubmed: 29743474
PLoS Pathog. 2008 Feb 29;4(2):e1000010
pubmed: 18389082
Cell Biol Int Rep. 1982 Jun;6(6):625-8
pubmed: 6286153
Clin Microbiol Rev. 2019 Jul 31;32(4):
pubmed: 31366609
Malar J. 2016 Sep 13;15:466
pubmed: 27618912
Malar J. 2018 Apr 3;17(1):143
pubmed: 29615050

Auteurs

Laurent Dembélé (L)

Sorbonne Université, INSERM, CNRS, INSERM U1135, Centre d'Immunologie et des Maladies Infectieuses, CIMI-Paris, Paris, France.
Université des Sciences, des Techniques et des Technologies de Bamako (USTTB), Bamako, Mali.
Malaria Research and Training Centre (MRTC), Faculty of Pharmacy, Bamako, Mali.

Jean-François Franetich (JF)

Sorbonne Université, INSERM, CNRS, INSERM U1135, Centre d'Immunologie et des Maladies Infectieuses, CIMI-Paris, Paris, France.

Valérie Soulard (V)

Sorbonne Université, INSERM, CNRS, INSERM U1135, Centre d'Immunologie et des Maladies Infectieuses, CIMI-Paris, Paris, France.

Nadia Amanzougaghene (N)

Sorbonne Université, INSERM, CNRS, INSERM U1135, Centre d'Immunologie et des Maladies Infectieuses, CIMI-Paris, Paris, France.

Shahin Tajeri (S)

Sorbonne Université, INSERM, CNRS, INSERM U1135, Centre d'Immunologie et des Maladies Infectieuses, CIMI-Paris, Paris, France.

Teun Bousema (T)

Department of Medical Microbiology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.

Geert-Jan van Gemert (GJ)

Department of Medical Microbiology, Radboud University Nijmegen Medical Center, Nijmegen, The Netherlands.

Roger Le Grand (R)

Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-Immune, Hematalogical and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France.

Nathalie Dereuddre-Bosquet (N)

Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-Immune, Hematalogical and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France.

J Kevin Baird (JK)

Eijkman-Oxford Clinical Research Unit, Jakarta, Indonesia kbaird@eocru.org.
Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom.

Dominique Mazier (D)

Sorbonne Université, INSERM, CNRS, INSERM U1135, Centre d'Immunologie et des Maladies Infectieuses, CIMI-Paris, Paris, France.

Georges Snounou (G)

Sorbonne Université, INSERM, CNRS, INSERM U1135, Centre d'Immunologie et des Maladies Infectieuses, CIMI-Paris, Paris, France.
Université Paris-Saclay, Inserm, CEA, Center for Immunology of Viral, Auto-Immune, Hematalogical and Bacterial Diseases (IMVA-HB/IDMIT), Fontenay-aux-Roses, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH